Analysis and Commentary STEVEN GROSSMAN 5/8/21 Analysis and Commentary STEVEN GROSSMAN 5/8/21 FDA Priorities for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More STEVEN GROSSMAN 4/12/21 STEVEN GROSSMAN 4/12/21 President's Budget Preview for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More STEVEN GROSSMAN 3/19/21 STEVEN GROSSMAN 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/8/21 Analysis and Commentary STEVEN GROSSMAN 5/8/21 FDA Priorities for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Key Take-Aways from Hill Day (Part One) Read More
Advocacy at a Glance STEVEN GROSSMAN 5/2/21 Advocacy at a Glance STEVEN GROSSMAN 5/2/21 The Alliance offers its perspective on the unique FY 22 budget. Hill Day Part One with House staff yields encouraging reactions. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Advocacy at a Glance STEVEN GROSSMAN 4/23/21 Alliance Hill Day Meetings on April 28-29, with Alliance member participation urgently requested. More on Acting FDA Commissioner Woodcock’s meeting with the Alliance. Read More
Analysis and Commentary STEVEN GROSSMAN 4/23/21 Analysis and Commentary STEVEN GROSSMAN 4/23/21 Alliance "Hill Day": April 28 and 29 Read More
Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
STEVEN GROSSMAN 3/19/21 STEVEN GROSSMAN 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More
Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
